GLECKEL LOUIS MD purchased 91.0% of their position (100K shares) of PROPHASE LABS, INC. on the open market
Open‑market purchase worth $175.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/27/2020ACC: 0001493152-20-004963
+100K
Net shares
Net buyer
$175.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
100K acquired
Non-Derivative Transactions1
Common Stock, par value $0.0005
Direct
Shares
+100K
Price / share
$1.75
Trade value
$175K
% of position
91.0%
3/26/2020
109.89K→209.89K
Total
Net shares
+100K
Net value
$175K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0005 Direct | 3/26/2020 | P · Purchase | +100K | $1.75 | $175K | 91.0% | 109.89K | 209.89K |
| Total | +100K | $175K | ||||||
Derivative Transactions0
No derivative transactions reported